1. Lectins in Health and Diseases: Galectins and Cancer
   Shirsha Nandi et al, 2021, Lectins CrossRef
2. Galectin-9 Induces Mitochondria-Mediated Apoptosis of Esophageal Cancer In Vitro and In Vivo in a Xenograft Mouse Model
   Taiga Chiyo et al, 2019, International Journal of Molecular Sciences CrossRef
3. Targeting the C-terminus of galectin-9 induces mesothelioma apoptosis and M2 macrophage depletion
   Pietro Bertino et al, 2019, OncoImmunology CrossRef
4. Epigenetic Bases of Aberrant Glycosylation in Cancer
   Fabio Dall’Olio et al, 2017, International Journal of Molecular Sciences CrossRef
5. Prognostic Value of Galectin-9 Relates to Programmed Death-Ligand 1 in Patients With Multiple Myeloma
   Byung-Hyun Lee et al, 2021, Frontiers in Oncology CrossRef
6. AllergoOncology – the impact of allergy in oncology: EAACI position paper
   E. Jensen‐Jarolim et al, 2017, Allergy CrossRef
7. Induction of apoptosis by Galectin-9 in liver metastatic cancer cells: In vitro study
   Tomoko Tadokoro et al, 2017, International Journal of Oncology CrossRef
8. Histone H3K9 and H3K14 acetylation at the promoter of the LGALS9 gene is associated with mRNA levels in cervical cancer cells
   Erick Armenta‐Castro et al, 2020, FEBS Open Bio CrossRef
9. Galectin-9 in cancer therapy: from immune checkpoint ligand to promising therapeutic target
   Minpu Zhang et al, 2024, Frontiers in Cell and Developmental Biology CrossRef
10. Galectin-9 Expression Predicts Favorable Clinical Outcome in Solid Tumors: A Systematic Review and Meta-Analysis
    Xiaoxiang Zhou et al, 2018, Frontiers in Physiology CrossRef
11. IgE Antibodies against Cancer: Efficacy and Safety
    Jitesh Chauhan et al, 2020, Antibodies CrossRef
12. Tumor-suppressive microRNA-551b-3p targets H6PD to inhibit gallbladder cancer progression
    Tao Ji et al, 2021, Cancer Gene Therapy CrossRef
13. The Proliferative Role of Immune Checkpoints in Tumors: Double Regulation
    Xi-Yang Tang et al, 2022, Cancers CrossRef
14. Effects of galectin-9 on apoptosis, cell cycle and autophagy in human esophageal adenocarcinoma cells
    Emiko Akashi et al, 2017, Oncology Reports CrossRef
15. Galectin-9-based immune risk score model helps to predict relapse in stage I–III small cell lung cancer
    Peixin Chen et al, 2020, Journal for ImmunoTherapy of Cancer CrossRef
16. Galectins as modulators of receptor tyrosine kinases signaling in health and disease
    Natalia Porębska et al, 2021, Cytokine & Growth Factor Reviews CrossRef
17. Cancer Therapy Due to Apoptosis: Galectin-9
    Koji Fujita et al, 2017, International Journal of Molecular Sciences CrossRef
18. Mutations in the DNA polymerase binding pathway affect the immune microenvironment of patients with small‐cell lung cancer and enhance the efficacy of platinum‐based chemotherapy
    Anqi Lin et al, 2023, Cancer Innovation CrossRef
19. Role of Galectins in Tumors and in Clinical Immunotherapy
    Feng-Cheng Chou et al, 2018, International Journal of Molecular Sciences CrossRef
20. Angiotensin receptor blocker telmisartan inhibits cell proliferation and tumor growth of cholangiocarcinoma through cell cycle arrest
    Eri Samukawa et al, 2017, International Journal of Oncology CrossRef
21. The interrelation of galectins and autophagy
    Lujuan Zheng et al, 2023, International Immunopharmacology CrossRef
22. The emerging role of galectins in high-fatality cancers
    Cherylane Dubé-Delarosbil et al, 2018, Cellular and Molecular Life Sciences CrossRef
23. Galectin-9 Changes Its Function to Maintain Homeostasis
    Mitsuomi Hirashima et al, 2018, Trends in Glycoscience and Glycotechnology CrossRef
24. Galectin-9: From cell biology to complex disease dynamics
    Sebastian John et al, 2016, Journal of Biosciences CrossRef
25. Glycan–Lectin Interactions in Cancer and Viral Infections and How to Disrupt Them
    Stefanie Maria Kremsreiter et al, 2021, International Journal of Molecular Sciences CrossRef